A Phase III, Randomized, Open, Parallel-controlled, Multi-center Study to Compare the Efficacy and Safety of Tacrolimus Capsules and Cyclophosphamide Injection in Treatment of Lupus Nephritis
Phase of Trial: Phase III
Latest Information Update: 01 Nov 2017
At a glance
- Drugs Tacrolimus (Primary) ; Cyclophosphamide; Prednisone
- Indications Lupus nephritis
- Focus Therapeutic Use
- Sponsors Astellas Pharma
- 13 Aug 2017 Planned End Date changed from 30 Jun 2018 to 1 Jun 2018.
- 13 Aug 2017 Planned primary completion date changed from 30 Jun 2018 to 1 Jun 2018.
- 10 Jun 2017 Biomarkers information updated